X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
venlafaxine (59) 59
humans (57) 57
index medicus (35) 35
female (31) 31
antidepressants (30) 30
pharmacology & pharmacy (29) 29
male (28) 28
adult (25) 25
venlafaxine hydrochloride (23) 23
double-blind (22) 22
psychiatry (21) 21
middle aged (19) 19
depression (17) 17
serotonin uptake inhibitors - therapeutic use (16) 16
overdose (15) 15
major depressive disorder (14) 14
aged (13) 13
adolescent (12) 12
antidepressive agents - therapeutic use (12) 12
citalopram (12) 12
cyclohexanols - poisoning (12) 12
depressive disorder, major - drug therapy (12) 12
drug overdose (12) 12
serotonin reuptake inhibitors (12) 12
antidepressive agents - adverse effects (11) 11
drug therapy (11) 11
serotonin uptake inhibitors - adverse effects (11) 11
toxicity (11) 11
drugs (10) 10
electrocardiography (10) 10
retrospective studies (10) 10
antidepressive agents, second-generation - adverse effects (9) 9
clinical neurology (9) 9
placebo-controlled trial (9) 9
risk factors (9) 9
treatment outcome (9) 9
antidepressant (8) 8
cyclohexanols - adverse effects (8) 8
electrocardiography - drug effects (8) 8
internal medicine (8) 8
long qt syndrome - chemically induced (8) 8
neurosciences (8) 8
pharmacokinetics (8) 8
poisoning (8) 8
research (8) 8
safety (8) 8
serotonin (8) 8
toxicology (8) 8
young adult (8) 8
antidepressive agents, second-generation - poisoning (7) 7
care and treatment (7) 7
complications and side effects (7) 7
cyclohexanols - administration & dosage (7) 7
duloxetine (7) 7
medicine & public health (7) 7
quetiapine (7) 7
serotonin uptake inhibitors (7) 7
venlafaxine hydrochloride - adverse effects (7) 7
abridged index medicus (6) 6
antidepressive agents - pharmacokinetics (6) 6
antipsychotic agents - therapeutic use (6) 6
depression - drug therapy (6) 6
medicine, general & internal (6) 6
metabolism (6) 6
mirtazapine (6) 6
paroxetine (6) 6
seizures (6) 6
tricyclic antidepressants (6) 6
antidepressive agents, second-generation - administration & dosage (5) 5
cyclohexanols - pharmacokinetics (5) 5
cyclohexanols - therapeutic use (5) 5
depression, mental (5) 5
depressive disorder - drug therapy (5) 5
dosage and administration (5) 5
dose-response relationship, drug (5) 5
efficacy (5) 5
fluoxetine (5) 5
mianserin - analogs & derivatives (5) 5
neuropathic pain (5) 5
pharmacology/toxicology (5) 5
qt prolongation (5) 5
randomized controlled-trial (5) 5
risk (5) 5
serotonin syndrome (5) 5
serotonin uptake inhibitors - poisoning (5) 5
aged, 80 and over (4) 4
analysis (4) 4
antidepressants, tricyclic (4) 4
antidepressive agents, second-generation - therapeutic use (4) 4
atypical antipsychotics (4) 4
case studies (4) 4
child (4) 4
drug dosages (4) 4
drug interactions (4) 4
duloxetine hydrochloride (4) 4
health aspects (4) 4
major depression (4) 4
pain (4) 4
pharmacology (4) 4
prescription drugs (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (74) 74
Bosnian (1) 1
Czech (1) 1
French (1) 1
German (1) 1
Russian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, ISSN 1017-7833, 09/2014, Volume 24, Issue 3, pp. 235 - 247
Objective: The rate of polypharmacy is increasing in patients with psychotic disorders. Polypharmacy is defined as the concomitant use of two or more drugs at... 
PSYCHIATRY | INPATIENTS | RISPERIDONE | schizophrenia | PREVALENCE | BIPOLAR DISORDER | psychotropic | QTC PROLONGATION | PRESCRIPTION | TORSADE-DE-POINTES | drug interaction | LITHIUM | polypharmacy | PLASMA-LEVEL | schizoaffective disorder | ANTIPSYCHOTIC POLYPHARMACY
Journal Article
Pharmacopsychiatry, ISSN 0176-3679, 01/2019, Volume 52, Issue 1, pp. 38 - 43
Abstract Introduction Many antidepressants cause QT prolongation but the classification of cardiac risk of these drugs varies markedly in different published... 
Original Paper | serum level | amitriptyline | QT prolongation | venlafaxine | therapeutic drug monitoring | C-REACTIVE PROTEIN | DEPRESSION | INTERVAL PROLONGATION | PSYCHIATRY | CITALOPRAM | PSYCHOTROPIC-DRUGS | RISK | THERAPY | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | ASSOCIATION
Journal Article
Journal Article
Journal Article
JOURNAL OF PALLIATIVE MEDICINE, ISSN 1096-6218, 05/2019, Volume 22, Issue 5, pp. 572 - 579
Palliative care (PC) providers often prescribe psychotropic medications to address psychological and physical suffering of patients with serious medical... 
QTc | POSTTRAUMATIC-STRESS-DISORDER | RECEIVING HOSPICE CARE | TORSADES-DE-POINTES | INDUCED QT-PROLONGATION | RAPID TREATMENT | quetiapine | palliative care | ATYPICAL ANTIPSYCHOTICS | insomnia | anxiety | SSRI | venlafaxine | SNRI | ORAL KETAMINE | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | SEDATIVE HYPNOTICS | depression | INDUCED WEIGHT-GAIN | benzodiazepine | delirium
Journal Article
Toxicologie Analytique et Clinique, ISSN 2352-0078, 09/2016, Volume 28, Issue 3, pp. 224 - 227
Case-report We report the case of a 42 years patient who absorbed 7875 mg of venlafaxine, 840 mg of escitalopram, 180 mg of bromazepam, and 14 mg of... 
Octreotide | Serotonin uptake inhibitors | Poisoning | Hypoglycemia | Venlafaxine hydrochloride
Journal Article
Journal Article
Journal of Medical Toxicology, ISSN 1556-9039, 3/2008, Volume 4, Issue 1, pp. 18 - 20
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2006, Volume 109, Issue 1, pp. 116 - 117
Journal Article
Journal Article
Biomedicinska istraživanja, ISSN 1986-8529, 07/2019, Volume 10, Issue 1, pp. 15 - 23
Introduction. Depressive disorder is common in patients with the diagnosis of alcoholism. Comorbidity of depression and alcoholism significantly worsens the... 
QT interval | comorbidity | venlafaxine | alcohol dependence | depression
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.